WorldCat Identities

Bendstrup, Elisabeth

Overview
Works: 17 works in 22 publications in 2 languages and 39 library holdings
Roles: Editor, Author, led, Other
Publication Timeline
.
Most widely held works by Elisabeth Bendstrup
Inhalation of heparin : aerosol characterisation, lung deposition and effect on systemic coagulation and lung function in healthy volunteers : Ph. D. dissertation by Elisabeth Bendstrup( Book )

3 editions published in 1999 in English and held by 6 WorldCat member libraries worldwide

Håndbog om idiopatisk pulmonal fibrose (IPF) til patienter og pårørende( Book )

3 editions published between 2017 and 2019 in Danish and held by 4 WorldCat member libraries worldwide

Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events by Ulrich Costabel( )

2 editions published in 2014 in English and held by 3 WorldCat member libraries worldwide

Pirfenidone is currently the only approved therapy for idiopathic pulmonary fibrosis, following studies demonstrating that treatment reduces the decline in lung function and improves progression-free survival. Although generally well tolerated, a minority of patients discontinue therapy due to gastrointestinal and skin-related adverse events (AEs). This review summarizes recommendations based on existing guidelines, research evidence, and consensus opinions of expert authors, with the aim of providing practicing physicians with the specific clinical information needed to educate the patient and better manage pirfenidone-related AEs with continued pirfenidone treatment. The main recommendations to help prevent and/or mitigate gastrointestinal and skin-related AEs include taking pirfenidone during (or after) a meal, avoiding sun exposure, wearing protective clothing, and applying a broad-spectrum sunscreen with high ultraviolet (UV) A and UVB protection. These measures can help optimize AE management, which is key to maintaining patients on an optimal treatment dose
Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events by Elisabeth Bendstrup( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis by Michael Kreuter( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis by Sissel Kronborg-White( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis by Thomas Skovhus Prior( )

1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide

Lungefibrose : en vejledning til patienter og pårørende( Book )

1 edition published in 2013 in Danish and held by 2 WorldCat member libraries worldwide

Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events by Ulrich Costabel( )

1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide

Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease by Wim A Wuyts( )

1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study by Marlies Wijsenbeek( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Lung Ultrasound - A Novel Diagnostic Tool To Phenotype Chronic Lung Allograft Dysfunction?( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis by Nils Hoyer( )

1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide

Validation of the IPF-specific version of St. George's Respiratory Questionnaire by Thomas Skovhus Prior( )

1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality by Charlotte Hyldgaard( )

1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide

Management of acute exacerbation of idiopathic pulmonary fibrosis in specialised and non-specialised ILD centres around the world by Markus Polke( )

1 edition published in 2021 in English and held by 1 WorldCat member library worldwide

Background: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is a severe complication associated with a high mortality. However, evidence and guidance on management is sparse. The aim of this international survey was to assess differences in prevention, diagnostic and treatment strategies for AE-IPF in specialised and non-specialised ILD centres worldwide.Material and Methods: Pulmonologists working in specialised and non-specialised ILD centres were invited to participate in a survey designed by an international expert panel. Responses were evaluated in respect to the physicians' institutions.Results: Three hundred and two (65%) of the respondents worked in a specialised ILD centre, 134 (29%) in a non-specialised pulmonology centre. Similarities were frequent with regards to diagnostic methods including radiology and screening for infection, treatment with corticosteroids, use of high-flow oxygen and non-invasive ventilation in critical ill patients and palliative strategies. However, differences were significant in terms of the use of KL-6 and pathogen testing in urine, treatments with cyclosporine and recombinant thrombomodulin, extracorporeal membrane oxygenation in critical ill patients as well as antacid medication and anaesthesia measures as preventive methods.Conclusion: Despite the absence of recommendations, approaches to the prevention, diagnosis and treatment of AE-IPF are comparable in specialised and non-specialised ILD centres, yet certain differences in the managements of AE-IPF exist. Clinical trials and guidelines are needed to improve patient care and prognosis in AE-IPF
COPD: an overlooked cause of excess mortality in patients with rheumatoid arthritis( )

1 edition published in 2018 in English and held by 1 WorldCat member library worldwide

 
moreShow More Titles
fewerShow Fewer Titles
Audience Level
0
Audience Level
1
  General Special  
Audience level: 0.97 (from 0.88 for Pirfenidon ... to 0.97 for Management ...)

Alternative Names
E Bendstrup wetenschapper

Elisabeth Bendstrup researcher

Languages
English (18)

Danish (4)